Drug Research
GDMC Secures US$21 Million Growth Capital Funding to Expand Global Genetic Medicines Design and Manufacturing Operations
Genetic Design and Manufacturing Corporation (GDMC), a design and manufacturing organization that focuses on next generation advanced genetic therapies, today announced a Series A funding of US$21 million. The funding round is led by Celadon Partners, an Asia private...
News
Pharmapack Europe Awards Winners 2024
Pharmapack Europe announces the winners of the prestigious 2024 Pharmapack Awards spanning four categories across two dedicated awards.
The Health Product Awards are open to the entire pharma industry – with winners in ‘eco-design’ and ‘patient-centric design’ – while the...
Clinical Trials
Long-Term Findings of CAR-NK Cell Therapy Look Promising
In a recent development, researchers from the US have gone on to report some promising outcomes out of a Phase I/II trial when it comes to cancer patients who get treated due to cord blood-led CD19-targeted chimeric antigen receptor-CAR...
Drug Research
Whole Genome Sequencing in Cancer Care: Strong Proof Seen
Blending the routine clinical data along with the whole genome sequence- WSG data at scale goes on to support clinicians when it comes to the delivery of precision cancer care, as per new landmark research.
Published in the journal Nature...
News
SGD Pharma Announces the Appointment of Fabio Invernizzi, General Manager West Business Unit
SGD Pharma, global primary glass packaging leader, has announced the appointment of Fabio Invernizzi as its new General Manager of its West BU.
The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing...
Drug Research
UK Study Validates Whole Genome Sequencing In Cancer Care
A novel benchmark study in the UK has gone on to show that blending whole-genome sequencing- WGS and real-world clinical data at a national scale can go on to help deliver customized cancer therapy.
The study, which got published in...
News
Pharma Companies Face An Abundance of Questions In 2024
The advent of powerful new drugs in the case of obesity has gone on to reshape the pharma sector, thereby transforming Eli Lilly as well as Novo Nordisk into the industry’s most valuable companies as well as giving others...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















